Carcinoembryonic antigen in thyroid cancer

M. Cimitan, B. Busnardo, M. E. Girelli, D. Casara, G. P. Zanatta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Serum levels of carcinoembryonic antigen (CEA) were measured by radioimmunoassay in 35 patients affected by various histological types of thyroid carcinoma: 9 papillary, 7 follicular, 4 undifferentiated, 15 medullary. All patients with nonmedullary thyroid carcinoma were studied preoperatively. No patient with follicular thyroid carcinoma showed CEA levels above normal limits (<0,5-10 ng/ml). Only 1 out of 9 patients with papillary thyroid carcinoma showed marginally elevated CEA levels (13 ng/ml). Of 4 patients with undifferentiated thyroid carcinoma 1 had high CEA levels (39 ng/ml) and 2 marginally elevated levels (12-13 ng/ml). High CEA levels (>320 ng/ml) were found in 2 of the 4 patients with medullary thyroid carcinoma studied before treatment and in the 4 patients (>320->320- 23-15 ng/ml) studied after total thyroidectomy alone; 3 of them had distant metastases. High levels (65-50-13 ng/ml) were also found in 3 other patients without metastases studied after total thyroidectomy plus radiotherapy. Thyroidectomy plus radiotherapy rapidly decreased CEA levels (from >320 to 20 ng/ml) in a patient without metastases, while the same treatment failed to reduce CEA levels consistently (from > 320 to 112 ng/ml) in a patient with distant metastases. The data suggest than high levels of CEA are frequent but not constant in patients with medullary thyroid carcinoma; in other histological types CEA is present only in sporadic cases. Since in the positive cases of medullary thyroid carcinoma CEA levels seem to be related to the effectiveness of the therapy, CEA assay may be useful in the management and follow up of this tumour.

Original languageEnglish
Pages (from-to)241-244
Number of pages4
JournalJournal of Endocrinological Investigation
Volume2
Issue number3
DOIs
Publication statusPublished - 1979

Fingerprint

Carcinoembryonic Antigen
Thyroid Neoplasms
Thyroidectomy
Neoplasm Metastasis
Radiotherapy
Follicular Adenocarcinoma
Radioimmunoassay
Therapeutics

Keywords

  • carcinoembryonic antigen
  • follow-up
  • medullary carcinoma
  • therapy
  • Thyroid cancer

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Cimitan, M., Busnardo, B., Girelli, M. E., Casara, D., & Zanatta, G. P. (1979). Carcinoembryonic antigen in thyroid cancer. Journal of Endocrinological Investigation, 2(3), 241-244. https://doi.org/10.1007/BF03350409

Carcinoembryonic antigen in thyroid cancer. / Cimitan, M.; Busnardo, B.; Girelli, M. E.; Casara, D.; Zanatta, G. P.

In: Journal of Endocrinological Investigation, Vol. 2, No. 3, 1979, p. 241-244.

Research output: Contribution to journalArticle

Cimitan, M, Busnardo, B, Girelli, ME, Casara, D & Zanatta, GP 1979, 'Carcinoembryonic antigen in thyroid cancer', Journal of Endocrinological Investigation, vol. 2, no. 3, pp. 241-244. https://doi.org/10.1007/BF03350409
Cimitan M, Busnardo B, Girelli ME, Casara D, Zanatta GP. Carcinoembryonic antigen in thyroid cancer. Journal of Endocrinological Investigation. 1979;2(3):241-244. https://doi.org/10.1007/BF03350409
Cimitan, M. ; Busnardo, B. ; Girelli, M. E. ; Casara, D. ; Zanatta, G. P. / Carcinoembryonic antigen in thyroid cancer. In: Journal of Endocrinological Investigation. 1979 ; Vol. 2, No. 3. pp. 241-244.
@article{f4327f3e8d034c319027b4bd44bbef34,
title = "Carcinoembryonic antigen in thyroid cancer",
abstract = "Serum levels of carcinoembryonic antigen (CEA) were measured by radioimmunoassay in 35 patients affected by various histological types of thyroid carcinoma: 9 papillary, 7 follicular, 4 undifferentiated, 15 medullary. All patients with nonmedullary thyroid carcinoma were studied preoperatively. No patient with follicular thyroid carcinoma showed CEA levels above normal limits (<0,5-10 ng/ml). Only 1 out of 9 patients with papillary thyroid carcinoma showed marginally elevated CEA levels (13 ng/ml). Of 4 patients with undifferentiated thyroid carcinoma 1 had high CEA levels (39 ng/ml) and 2 marginally elevated levels (12-13 ng/ml). High CEA levels (>320 ng/ml) were found in 2 of the 4 patients with medullary thyroid carcinoma studied before treatment and in the 4 patients (>320->320- 23-15 ng/ml) studied after total thyroidectomy alone; 3 of them had distant metastases. High levels (65-50-13 ng/ml) were also found in 3 other patients without metastases studied after total thyroidectomy plus radiotherapy. Thyroidectomy plus radiotherapy rapidly decreased CEA levels (from >320 to 20 ng/ml) in a patient without metastases, while the same treatment failed to reduce CEA levels consistently (from > 320 to 112 ng/ml) in a patient with distant metastases. The data suggest than high levels of CEA are frequent but not constant in patients with medullary thyroid carcinoma; in other histological types CEA is present only in sporadic cases. Since in the positive cases of medullary thyroid carcinoma CEA levels seem to be related to the effectiveness of the therapy, CEA assay may be useful in the management and follow up of this tumour.",
keywords = "carcinoembryonic antigen, follow-up, medullary carcinoma, therapy, Thyroid cancer",
author = "M. Cimitan and B. Busnardo and Girelli, {M. E.} and D. Casara and Zanatta, {G. P.}",
year = "1979",
doi = "10.1007/BF03350409",
language = "English",
volume = "2",
pages = "241--244",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "3",

}

TY - JOUR

T1 - Carcinoembryonic antigen in thyroid cancer

AU - Cimitan, M.

AU - Busnardo, B.

AU - Girelli, M. E.

AU - Casara, D.

AU - Zanatta, G. P.

PY - 1979

Y1 - 1979

N2 - Serum levels of carcinoembryonic antigen (CEA) were measured by radioimmunoassay in 35 patients affected by various histological types of thyroid carcinoma: 9 papillary, 7 follicular, 4 undifferentiated, 15 medullary. All patients with nonmedullary thyroid carcinoma were studied preoperatively. No patient with follicular thyroid carcinoma showed CEA levels above normal limits (<0,5-10 ng/ml). Only 1 out of 9 patients with papillary thyroid carcinoma showed marginally elevated CEA levels (13 ng/ml). Of 4 patients with undifferentiated thyroid carcinoma 1 had high CEA levels (39 ng/ml) and 2 marginally elevated levels (12-13 ng/ml). High CEA levels (>320 ng/ml) were found in 2 of the 4 patients with medullary thyroid carcinoma studied before treatment and in the 4 patients (>320->320- 23-15 ng/ml) studied after total thyroidectomy alone; 3 of them had distant metastases. High levels (65-50-13 ng/ml) were also found in 3 other patients without metastases studied after total thyroidectomy plus radiotherapy. Thyroidectomy plus radiotherapy rapidly decreased CEA levels (from >320 to 20 ng/ml) in a patient without metastases, while the same treatment failed to reduce CEA levels consistently (from > 320 to 112 ng/ml) in a patient with distant metastases. The data suggest than high levels of CEA are frequent but not constant in patients with medullary thyroid carcinoma; in other histological types CEA is present only in sporadic cases. Since in the positive cases of medullary thyroid carcinoma CEA levels seem to be related to the effectiveness of the therapy, CEA assay may be useful in the management and follow up of this tumour.

AB - Serum levels of carcinoembryonic antigen (CEA) were measured by radioimmunoassay in 35 patients affected by various histological types of thyroid carcinoma: 9 papillary, 7 follicular, 4 undifferentiated, 15 medullary. All patients with nonmedullary thyroid carcinoma were studied preoperatively. No patient with follicular thyroid carcinoma showed CEA levels above normal limits (<0,5-10 ng/ml). Only 1 out of 9 patients with papillary thyroid carcinoma showed marginally elevated CEA levels (13 ng/ml). Of 4 patients with undifferentiated thyroid carcinoma 1 had high CEA levels (39 ng/ml) and 2 marginally elevated levels (12-13 ng/ml). High CEA levels (>320 ng/ml) were found in 2 of the 4 patients with medullary thyroid carcinoma studied before treatment and in the 4 patients (>320->320- 23-15 ng/ml) studied after total thyroidectomy alone; 3 of them had distant metastases. High levels (65-50-13 ng/ml) were also found in 3 other patients without metastases studied after total thyroidectomy plus radiotherapy. Thyroidectomy plus radiotherapy rapidly decreased CEA levels (from >320 to 20 ng/ml) in a patient without metastases, while the same treatment failed to reduce CEA levels consistently (from > 320 to 112 ng/ml) in a patient with distant metastases. The data suggest than high levels of CEA are frequent but not constant in patients with medullary thyroid carcinoma; in other histological types CEA is present only in sporadic cases. Since in the positive cases of medullary thyroid carcinoma CEA levels seem to be related to the effectiveness of the therapy, CEA assay may be useful in the management and follow up of this tumour.

KW - carcinoembryonic antigen

KW - follow-up

KW - medullary carcinoma

KW - therapy

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=0018733480&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018733480&partnerID=8YFLogxK

U2 - 10.1007/BF03350409

DO - 10.1007/BF03350409

M3 - Article

C2 - 528775

AN - SCOPUS:0018733480

VL - 2

SP - 241

EP - 244

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 3

ER -